Thursday, 29 November 2012
Shares in home-grown biotech star CSL shot above $50 on an upgraded profit outlook. Is it too late to buy? James Dunn analyses CSL's outlook.
Monday, 26 November 2012
Bonds form an important part of a diversified investment portfolio. But don't make the mistake of thinking fixed interest means risk free. Here are two risks to watch.
Thursday, 22 November 2012
It’s the battle of the big airlines – Qantas and Virgin Australia. But should you choose either of these stocks for your SMSF portfolio?
Wednesday, 21 November 2012
Cash-flow positive property means your SMSF benefits from direct income from day one. But are they all they’re cracked up to be?
Monday, 19 November 2012
With fiscal cliff concerns prevailing and markets heading lower, how long until it’s all under control and stocks head higher again?